Additional file 1: of The neoepitope landscape of breast cancer: implications for immunotherapy

Table S1. Number of patients for breast cancer subtype in the TCGA dataset according to IHC status. Sample sizes of the initial dataset, and for samples that were able to be included at each stage (mutation burden calling, neoepitope load estimation, and then gene expression analysis), are reported for each of the three breast cancer subtype categories (ER/PR(+)HER-2(â ), HER-2(+), TNBC) (PDF 56 kb)